Hamasat Abd Elhafeez Abd Elkhalek Abd Elkader Elnoury
Asst. Professor
Pregnancy-Associated Placental Protein A2/Placental Growth Factor Ratio Might Discriminate Normotensive Pregnant Women Who Are Liable to Develop Early-Onset Preeclampsia
• 2023
Publication Information
Authors
Heba E. Abdel Raziq1, Amira E. Khalil1, Hamasat A Alnoury2,4*, George N.B. Morcos3,4, Moataz Maher
Kamel3,4
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Objectives: Evaluation of the ability of serum Pregnancy-associated Placental Protein A2 (PAPP-A2), Placental growth
factor (PLGF) and soluble fms-like tyrosine kinase 1 (sFlt-1) levels estimated at the 12th gestational weeks (GW) to predict
the possibility of development of preeclampsia (PE) in the normotensive pregnant women.
Patients: 66 PE and 66 No-PE women gave blood samples at the 12th GW for ELISA estimation of study biomarkers. During
pregnancy, 21 women had early-onset and 19 women had severe PE. Study outcome is the ability of serum cytokines' levels
estimated at the 12th GW for prediction of oncoming PE development.
Results: Blood pressure (BP) measures were significantly higher in PE women than their baseline measures and
corresponding measures of women of No-PE group. Serum levels of PAPP-A2 and sFlt-1 were significantly higher, while
levels of PLGF were significantly lower in PE than in No-PE women. ROC curve analysis defined PAPP-A2/PLGF ratio
>0.51 as discriminator point for early-onset PE with moderate accuracy (AUC=0.662; 95% CI: 0.264-0.982) and sensitivity
rate of 90.48% and negative predictive value of 94.12%.
Conclusion: Determination of PAPP-A2/PLGF ratio in serum at the 12 GW might be used as early predictor for PE and
ratio at >0.51 could predict early-onset PE with moderate accuracy.
factor (PLGF) and soluble fms-like tyrosine kinase 1 (sFlt-1) levels estimated at the 12th gestational weeks (GW) to predict
the possibility of development of preeclampsia (PE) in the normotensive pregnant women.
Patients: 66 PE and 66 No-PE women gave blood samples at the 12th GW for ELISA estimation of study biomarkers. During
pregnancy, 21 women had early-onset and 19 women had severe PE. Study outcome is the ability of serum cytokines' levels
estimated at the 12th GW for prediction of oncoming PE development.
Results: Blood pressure (BP) measures were significantly higher in PE women than their baseline measures and
corresponding measures of women of No-PE group. Serum levels of PAPP-A2 and sFlt-1 were significantly higher, while
levels of PLGF were significantly lower in PE than in No-PE women. ROC curve analysis defined PAPP-A2/PLGF ratio
>0.51 as discriminator point for early-onset PE with moderate accuracy (AUC=0.662; 95% CI: 0.264-0.982) and sensitivity
rate of 90.48% and negative predictive value of 94.12%.
Conclusion: Determination of PAPP-A2/PLGF ratio in serum at the 12 GW might be used as early predictor for PE and
ratio at >0.51 could predict early-onset PE with moderate accuracy.